Renal function in children with congenital neurogenic bladder
Carregando...
Citações na Scopus
24
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Citação
CLINICS, v.66, n.2, p.189-195, 2011
Resumo
AIMS: Preservation of renal function in children with congenital neurogenic bladder is an important goal of treatment for the disease. This study analyzed the evolution of renal function in patients with congenital neurogenic bladder. METHODS: We reviewed the records of 58 pediatric patients with respect to the following attributes: gender, age, etiology of neurogenic bladder, reason for referral, medical/surgical management, episodes of treated urinary tract infections, urodynamics, DMSA scintigraphy, weight, height, blood pressure, glomerular filtration rate, microalbuminuria and metabolic acidosis. Statistical analysis was performed, adopting the 5% significance level. RESULTS: The mean age at presentation was 4.2 +/- 3.5 years. Myelomeningocele was the most frequent etiology (71.4%). Recurrent urinary tract infection was the reason for referral in 82.8% of the patients. Recurrent urinary tract infections were diagnosed in 84.5% of the patients initially; 83.7% of those patients experienced improvement during follow-up. The initial mean glomerular filtration rate was 146.7 +/- 70.1 mL/1.73 m(2)/min, and the final mean was 193.6 +/- 93.6 mL/1.73 m(2)/min, p = 0.0004. Microalbuminuria was diagnosed in 54.1% of the patients initially and in 69% in the final evaluation. Metabolic acidosis was present in 19% of the patients initially and in 32.8% in the final assessment. CONCLUSIONS: Patient referral to a pediatric nephrologist was late. A reduction in the number of urinary tract infections was observed with adequate treatment, but microalbuminuria and metabolic acidosis occurred frequently despite adequate management.
Palavras-chave
Neurogenic Bladder, Microalbuminuria, Acidosis, Children, Renal Function
Referências
- American Diabetes Association Clinical Practice Recommendations, 2001, DIABETES CARE S1, V24, pS1
- SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571
- Dik P, 2006, EUR UROL, V49, P908, DOI 10.1016/j.eururo.2005.12.056
- de Jong PE, 2006, J AM SOC NEPHROL, V17, P2120, DOI 10.1681/ASN.2006010097
- Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222
- DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P749
- Battle D. C., 1981, NEW ENGL J MED, V304, P373
- CASS AS, 1984, J UROLOGY, V132, P521
- CASS AS, 1984, J UROLOGY, V132, P526
- Del Gado R, 2003, J UROLOGY, V170, P1960, DOI 10.1097/01.ju.0000091874.91613.af
- GHONIEM GM, 1990, J UROLOGY, V144, P1440
- HAYESALL.MC, 1972, DEV MED CHILD NEUROL, V14, P59
- Kari JA, 2006, PEDIATR NEPHROL, V21, P517, DOI 10.1007/s00467-006-0034-5
- Mingin GC, 2002, PEDIATRICS, V110, P1193, DOI 10.1542/peds.110.6.1193
- Rodriguez Soriano Juan, 2002, Journal of the American Society of Nephrology, V13, P2160, DOI 10.1097/01.ASN.0000023430.92674.E5
- ROSENBLUM MF, 1983, DEV MED CHILD NEUROL, V25, P338
- Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415
- Sutherland RW, 1997, J UROLOGY, V158, P1265, DOI 10.1016/S0022-5347(01)64450-1
- Ulsenheimer MMM, 2004, ARQ NEURO-PSIQUIAT, V62, P963, DOI 10.1590/S0004-282X2004000600006